LAPSE:2019.1652
Published Article
LAPSE:2019.1652
Green Synthesized Silver Nanoparticles of Myrtus communis L (AgMC) Extract Inhibits Cancer Hallmarks via Targeting Aldose Reductase (AR) and Associated Signaling Network
Abdulwahab Ali Abuderman, Rabbani Syed, Abdullah A. Alyousef, Mohammed S. Alqahtani, Mohammad Shamsul Ola, Abdul Malik
December 16, 2019
In this current study, we demonstrated the green synthesis and characterization of silver nanoparticles using Myrtus communis L. plant extract (Ag-MC) and its evaluation of anticancer and antimicrobial activities. The green synthesis of (Ag-MC), was assessed by numerous characterization techniques such as ultraviolet-visible spectroscopy (UV-VIS), Fourier-transform infrared spectroscopy (FT-IR), X-ray powder diffraction (XRD) transmission electron microscopy (TEM) and energy dispersive x-ray spectroscopy (EDX). The anti-cancer activity of the green synthesized silver nanoparticles was evaluated by the median inhibitory dose (IC50) on human liver carcinoma cell lines (HepG2). These results suggested that SN-NPs can be used as effective anticancer cell lines, as well as antibacterial and antiseptic agents in the medical field. This study showed that overexpression of aldose reductase (AR) in the human liver carcinoma cell line, HepG2, was down regulated by administration of SN-MC. The down regulation of AR was associated with abrogation of Pl3k/Akt, ERK and NF-kB pathways and the inhibition of cancer hallmarks, however, the target molecule for Ag-MC was not practically established. Thus it is still unknown if the consequences were due to AR inhibition or direct Ag-MC interaction with AR.
Keywords
anti-cancer, green synthesis, Myrtus communis L., silver NPs
Subject
Suggested Citation
Ali Abuderman A, Syed R, A. Alyousef A, S. Alqahtani M, Shamsul Ola M, Malik A. Green Synthesized Silver Nanoparticles of Myrtus communis L (AgMC) Extract Inhibits Cancer Hallmarks via Targeting Aldose Reductase (AR) and Associated Signaling Network. (2019). LAPSE:2019.1652
Author Affiliations
Ali Abuderman A: Basic Medical Science Department, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj 16278, Saudi Arabia
Syed R: Department of Pharmaceutics, College of Pharmacy, PO Box 2457, King Saud University, Riyadh 11451, Saudi Arabia; Nano medicine Research unit (MNU), Pharmaceutical department, college of pharmacy, King Saud University. Riyadh 11451, Saudi Arabia
A. Alyousef A: Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Saud University, Riyadh 11451, Saudi Arabia
S. Alqahtani M: Department of Pharmaceutics, College of Pharmacy, PO Box 2457, King Saud University, Riyadh 11451, Saudi Arabia
Shamsul Ola M: Department of Biochemistry, College of Science, King Saud University, P.O. Box 2455, King Saud University, Riyadh 11451, Saudi Arabia
Malik A: Department of Pharmaceutics, College of Pharmacy, PO Box 2457, King Saud University, Riyadh 11451, Saudi Arabia; Nano medicine Research unit (MNU), Pharmaceutical department, college of pharmacy, King Saud University. Riyadh 11451, Saudi Arabia
Journal Name
Processes
Volume
7
Issue
11
Article Number
E860
Year
2019
Publication Date
2019-11-18
Published Version
ISSN
2227-9717
Version Comments
Original Submission
Other Meta
PII: pr7110860, Publication Type: Journal Article
Record Map
Published Article

LAPSE:2019.1652
This Record
External Link

doi:10.3390/pr7110860
Publisher Version
Download
Files
[Download 1v1.pdf] (2.7 MB)
Dec 16, 2019
Main Article
License
CC BY 4.0
Meta
Record Statistics
Record Views
656
Version History
[v1] (Original Submission)
Dec 16, 2019
 
Verified by curator on
Dec 16, 2019
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2019.1652
 
Original Submitter
Calvin Tsay
Links to Related Works
Directly Related to This Work
Publisher Version